Cancer News and Research

Latest Cancer News and Research

DSMB recommends continuation of Genticel’s GTL001 phase 2 trial in HPV-infected women

DSMB recommends continuation of Genticel’s GTL001 phase 2 trial in HPV-infected women

ACCC launches new initiative to facilitate adoption of immuno-oncology in community cancer setting

ACCC launches new initiative to facilitate adoption of immuno-oncology in community cancer setting

Researchers identify link between hormonal factors and endometrial cancer risk among women with Lynch syndrome

Researchers identify link between hormonal factors and endometrial cancer risk among women with Lynch syndrome

Study: Extended-field IMRT for cervical or endometrial cancer does not increase risk of duodenal toxicity

Study: Extended-field IMRT for cervical or endometrial cancer does not increase risk of duodenal toxicity

Chromosomal abnormalities in embryos created for IVF can be predicted at earliest stage of human development

Chromosomal abnormalities in embryos created for IVF can be predicted at earliest stage of human development

Researchers develop novel technique to generate activated T cells to tackle advanced melanoma

Researchers develop novel technique to generate activated T cells to tackle advanced melanoma

UC researcher awarded NCI grant to study effect of MED1 protein on HER2-positive breast cancer

UC researcher awarded NCI grant to study effect of MED1 protein on HER2-positive breast cancer

Study looks at effects of three levels of vitamin D supplementation in overweight, obese blacks

Study looks at effects of three levels of vitamin D supplementation in overweight, obese blacks

MGH-CEM researchers develop microfabricated device to analyze effects of pro-drugs on cancer cells

MGH-CEM researchers develop microfabricated device to analyze effects of pro-drugs on cancer cells

IRB Barcelona scientists provide molecular details about Seckel Syndrome

IRB Barcelona scientists provide molecular details about Seckel Syndrome

UC Davis scientists identify significant driver of neuropathic pain

UC Davis scientists identify significant driver of neuropathic pain

University of Adelaide researchers develop laser system for onsite breath analysis

University of Adelaide researchers develop laser system for onsite breath analysis

Spotting the symptoms of advanced prostate cancer: an interview with Brian Tomlinson

Spotting the symptoms of advanced prostate cancer: an interview with Brian Tomlinson

Southern Research receives $22 million to support HIV cure initiative

Southern Research receives $22 million to support HIV cure initiative

NCC of South Korea, Velos agree to expand use of Velos eResearch for cancer research

NCC of South Korea, Velos agree to expand use of Velos eResearch for cancer research

New public guide addresses unrealistic expectations of screening tests

New public guide addresses unrealistic expectations of screening tests

Aspirin may inhibit the growth of mesothelioma, shows study

Aspirin may inhibit the growth of mesothelioma, shows study

15-20% women overdiagnosed in Norway's Breast Cancer Screening Programme

15-20% women overdiagnosed in Norway's Breast Cancer Screening Programme

Tests reveal that FY26 cancer drug is 49 times more potent than Cisplatin drug

Tests reveal that FY26 cancer drug is 49 times more potent than Cisplatin drug

CPhA urges federal government to enhance HPV vaccination programs for young Canadians

CPhA urges federal government to enhance HPV vaccination programs for young Canadians

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.